Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | WIZ | O95785 | 6/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.45 |
| ▸ | IKZF2 | Q9UKS7 | 6/20 | 0.40 |
| ▸ | CRBN | Q96SW2 | 3/20 | 0.40 |
| ▸ | GSPT1 | P15170 | 1/20 | 0.40 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.40 |
| ▸ | IKZF3 | Q9UKT9 | 1/20 | 0.40 |
| ▸ | IKZF1 | Q13422 | 1/20 | 0.39 |
| ▸ | TNF | P01375 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL34466553 | 0.96 | MAPT (0.47) | WIZMAPTIKZF2CRBNGSPT1 | |
| SCHEMBL34466084 | 0.93 | MAPT (0.47) | WIZMAPTIKZF2CRBN | |
| SCHEMBL34465878 | 0.89 | CRBN (0.47) | IKZF2CRBNGSPT1DDB1IKZF3 | |
| SCHEMBL34465859 | 0.89 | IKZF2 (0.47) | WIZMAPTIKZF2CRBNIKZF1 | |
| SCHEMBL34466436 | 0.88 | WIZ (0.43) | WIZMAPTIKZF2CRBNGSPT1 | |
| SCHEMBL34465616 | 0.88 | CRBN (0.47) | WIZMAPTIKZF2CRBNGSPT1 | |
| SCHEMBL34466532 | 0.84 | MAPT (0.46) | WIZMAPTIKZF2CRBNGSPT1 | |
| SCHEMBL34466511 | 0.84 | WIZ (0.44) | WIZMAPTIKZF2CRBNGSPT1 | |
| SCHEMBL34466106 | 0.84 | MAPT (0.49) | WIZMAPTIKZF2CRBNGSPT1 | |
| SCHEMBL34466313 | 0.84 | IKZF2 (0.48) | WIZMAPTIKZF2CRBNIKZF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260109702-A1 | NOVEL GSPT PROTEIN DEGRADER AND APPLICATION THEREOF | GENOSCO INC (US) | 2026-04-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260109702-A1 | NOVEL GSPT PROTEIN DEGRADER AND APPLICATION THEREOF | CRBN, PSMB3, PSMB1 | WIZ 1242/4885MAPT 3675/4885IKZF2 1736/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.